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MaturationHypoxia inducible factor (HIF) 1a, EPAS1 and NEPAS are expressed in the embryonic mouse lung and each
isoform exhibits distinct spatiotemporal expression patterns throughout morphogenesis. To further assess
the role of the HIF1a isoform in lung epithelial cell differentiation and homeostasis, we created transgenic
mice that express a constitutively active isoform of human HIF-1a (HIF-1a three point mutant (TPM)), in a
doxycycline-dependent manner. Expression of HIF1a TPM in the developing pulmonary epithelium resulted
in lung hypoplasia characterized by defective branching morphogenesis, altered cellular energetics and im-
paired epithelial maturation, culminating in neonatal lethality at birth from severe respiratory distress. His-
tological and biochemical analyses revealed expanded glycogen pools in the pulmonary epithelial cells at
E18.5, concomitant with decreased pulmonary surfactant, suggesting a delay or an arrest in maturation. Im-
portantly, these defects occurred in the absence of apoptosis or necrosis. In addition, sub-pleural hemorrhag-
ing was evident as early as E14.5 in HIF1a TPM lungs, despite normal patterning of the blood vasculature,
consistent with defects in endothelial barrier function. Epithelial expression of HIF1a TPM also resulted in in-
creased VEGFA and VEGFC production, an increase in the number of lymphatic vessels and indirect activation
of the multiple Notch pathway components in endothelial precursor cells. Collectively, these data indicate
that HIF-1a protein levels in the pulmonary epithelium must be tightly controlled for proper development
of the epithelial and mesenchymal compartments.
© 2011 Elsevier Inc. All rights reserved.Introduction
Formation of the mammalian embryonic lung depends on many
interdependent processes including branching of the endodermally-
derived epithelium into the surrounding mesenchyme, development
of the blood and lymphatic vasculature, and speciﬁcation andmatura-
tion of multiple cell types within both tissue compartments. Previous
studies have demonstrated that the fetal lung is relatively hypoxic in
utero (Lee et al., 2001), suggesting that low oxygen levels may
promote lung organogenesis. Consistent with this concept, both
branching morphogenesis and vascular development are enhanced
in rodent lung explants exposed to a hypoxic environment relative
to those cultured in ambient O2 tensions (Gebb and Jones, 2003;
Gebb et al., 2005; van Tuyl et al., 2005).
Organismal adaptation to low oxygen levels is primarily regulated
at the transcriptional level by hypoxia-inducible factors (HIFs). HIFs
are heterodimeric transcription factors comprised of an oxygen-
sensitive alpha subunit (1a, 2a or 3a) and a constitutively expressed
beta subunit (1b, also referred to as aryl hydrocarbon receptorBiology, Cincinnati Children's
9, Cincinnati, OH 45229, USA.
es).
rights reserved.nuclear translocator (ARNT)). All three alpha subunits, as well as
ARNT, are critical modulators of embryonic mouse development as
demonstrated in gene ablation studies (Compernolle et al., 2002;
Iyer et al., 1998; Maltepe et al., 1997; Ryan et al., 1998; Scortegagna
et al., 2003; Yamashita et al., 2008). HIF1a activity is largely regulated
at the level of protein stability, governed by a family of prolyl hydrox-
ylase domain (PHD)-containing enzymes, PHD1, 2 and 3 (Bruick and
McKnight, 2001; Epstein et al., 2001; Ivan et al., 2002). Under nor-
moxic conditions, the PHDs hydroxylate two conserved proline resi-
dues within the oxygen-dependent degradation domain (ODD) of
human HIF1a, P402 and P564, in a process that requires O2, Fe2+
and 2-oxoglutarate. Hydroxylated HIF1a is then recognized by the
E3 ubiquitin complex von-Hippel–Lindau (pVHL), tagged with polyu-
biquitin and degraded by the 26S proteasome (see (Schoﬁeld and
Ratcliffe, 2004) for review). In hypoxia, PHD-mediated hydroxylation
is inhibited and HIF1a escapes proteasomal degradation. Stable HIF1a
subunits then accumulate in the cytoplasm and translocate into the
nucleus where they interact with ARNT. Functional HIF1a/ARNT di-
mers bind a conserved DNA binding motif known as the hypoxia re-
sponsive element (HRE) and activate a large number of target genes
that regulate oxygen delivery, energy maintenance and survival
(Wenger et al., 2005). In addition to regulation at the protein stability
level, HIF1a transcriptional activity is also controlled via hydroxyl-
ation by the asparaginyl hydroxylase factor inhibiting HIF (FIH)
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(N803) and prevents interaction with the potent co-activator p300/
CBP, thereby dampening the transcriptional activation of HIF1a
under normoxic conditions (Ema et al., 1999; Lando et al., 2002b).
HIF1a protein is present at low levels in normoxia-cultured primary
and transformed pulmonary cell types derived from multiple species
and is highly induced under hypoxic conditions (Yu et al., 1998). En-
dogenous HIF1a and ARNT are primarily restricted to epithelial cells
of the ﬁrst trimester human fetal lung (Groenman et al., 2007), sug-
gesting a role for epithelial HIF1a signaling in pulmonary development
and/or maturation. In agreement, Cre-mediated deletion of HIF1a from
the developing pulmonary epithelium using the Sftpc-rtTA/tetO7-Cre
system has been reported to result in neonatal respiratory distress as-
sociated with decreased maturation of distal epithelial cells (Saini et
al., 2008). In extremely premature infants, respiratory distress is a com-
mon morbidity resulting from insufﬁcient maturation of the lung. This
perturbation of maturation, coupled with mechanical ventilatory sup-
port, is thought to underlie the susceptibility of this patient population
to developing a form of chronic lung disease known as bronchopul-
monary dysplasia (BPD) (Baraldi and Filippone, 2007). Studies per-
formed in large animal models of BPD have shown that HIF1a protein
is decreased in the premature lung, associated with decreased vascu-
larization and diminished levels of a pivotal HIF1a target gene, Vegfa
(Asikainen et al., 2005, 2006b; Grover et al., 2007); chemical stabiliza-
tion of HIF1a in the premature baboon model dramatically improved
the pathophysiological pulmonary abnormalities (Asikainen et al.,
2006a). Collectively, these data demonstrate that HIF1a signaling is re-
quired for the proper maturation and function of alveolar type II cells
during fetal lung development.
The goals of the present study were to deﬁne the expression levels
and localization patterns of endogenous HIF subunits during mouse
lung development, to further deﬁne the functional role of HIF1a in
the developing respiratory epithelium and to identify HIF1a target
genes that mediate epithelial maturation. Toward these goals we gen-
erated transgenic mice that individually expressed two distinct
normoxia-stable isoforms of HIF1a in the pulmonary epithelium in a
conditional manner. Our results show that augmented expression of
HIF1a in the developing pulmonary epithelium disrupts branching
morphogenesis, associated with decreased epithelial cell prolifera-
tion, metabolic switching to a glycolytic phenotype and impaired
maturation. HIF1a induction in the fetal respiratory epithelium also
caused pulmonary vascular abnormalities, including hemorrhaging
and a marked increase in lymphangiogenesis. These data demon-
strate that excessive HIF1a activation in the fetal pulmonary epitheli-
um resulted in developmental and maturational defects, suggesting
that conditions that promote epithelial HIF1a stability and activation
in uteromay negatively impact pulmonary development and function.
Materials and methods
Expression constructs and transgenic animals
The HIF1a ΔODD,N803A (amino acids 401–603 deleted, Asn803
mutated to Ala) and TPM constructs (Pro402, Pro564, and Asn803
mutated to Ala) were generated by PCR mutagenesis using human
HIF1a cDNA as a template. A single HA-tag was cloned in frame to
the C-terminus of both constructs by PCR. HA-tagged HIF1a ΔODD,
N803A and TPM cDNAs were cloned into pcDNA3.1+ (Invitrogen,
Carlsbad, CA) for use in transient transfection assays.
The HIF1a ΔODD,N803A transgenic construct was generated by
subcloning the HIF1a ΔODD,N803A cDNA into the tetracycline-
responsive pTRE-tight vector (Clontech, Mountain View, CA). The
HIF1a TPM transgenic construct was generated in the following man-
ner. First, the IRES sequence was PCR ampliﬁed from the pIRES2-EGFP
vector (Clontech, Mountain View, CA) and cloned into the multiple
cloning site of the (teto)7CMV-bGH-poly(A) vector, kindly providedby Dr. Herman Bujard (Gossen and Bujard, 1992). Next, a FLAG-
tagged human ARNT cDNA was cloned 3′ of the IRES sequence and
the HIF1a TPM cDNA was cloned 5′ of the IRES sequence to generate
the ﬁnal construct. The constructs were linearized and microinjected
individually into the pronucleus of fertilized eggs from FVB/N mice.
The HIF1a ΔODD,N803A transgene was identiﬁed by PCR using the
primers: 5′-AGCACGACTTGATTTTCTCCC-3′ and 5′-CATCCATTGAT-
TGCCCCAG-3′. The HIF1a TPM transgene was identiﬁed using the
primers: 5′-TGGATTACCACAGCTGACCA-3′ and 5′-AGGAACTGCTTC-
CTTCACGA-3′. To target the respiratory epithelium, the 3.7-kb
human Sftpc promoter was used to drive the reverse tetracycline
transactivator (rtTA). hSftpc-rtTA mice (line 1) (Perl et al., 2009)
were mated to (tetO)7CMVHIF1a ΔODD,N803A and (tetO)7CMVHIF1a
TPM mice to generate double transgenic hSftpc-rtTAtg/wt, (tetO)7
CMVHIF1a ΔODD,N803Atg/wt (hereafter, HIF1a ΔODD,N803A) and
hSftpc-rtTAtg/wt, (tetO)7CMVHIF1a TPMtg/wt (hereafter, HIF1a TPM)
mice, respectively. The hSftpc-rtTA transgene was identiﬁed using
the primers: 5′-GACACATATAAGACCCTGGTCA-3′ and 5′-AAAATC-
TTGCCAGCTTTCCCC-3′. The HIF1 transgenes were induced in respira-
tory epithelial cells of double transgenic mice by administering
doxycycline in the food at a concentration of 525 mg/kg dry weight
(Harlan Teklad, Madison, WI) at times indicated in the Results sec-
tion. Mice were maintained in a pathogen-free environment in accor-
dance with protocols approved by the Institutional Animal Care and
Use Committee of the Children's Hospital Research Foundation.
Generation of HIF1a antisera
The cDNAencoding amino acids 644–803of humanHIF1aproteinwas
ampliﬁed from HIF1a WT/pcDNA3.1+ and cloned into the pET41a+
vector (Novagen) to create hHIF1a(644–803)/pET41a+. BL21(DE3)
bacteria were transformed with hHIF1a(644–803)/pET41a+, grown to
log phase and induced with 1 mM IPTG for 4 h to produce the recombi-
nant protein. The proteinwas then isolated from lysed cells by nickel col-
umn puriﬁcation and injected into guinea pigswith adjuvant to generate
polyclonal antibodies. Primary sera were collected and passed through a
GST column to adsorb anti-GST antibodies prior to use.
Saturated phosphatidylcholine (SatPC) and total glycogen assays
Embryonic lungs were placed in 0.9% saline and pulse sonicated
on ice. Lipids were extracted from the samples by the Bligh and
Dyer method (Bligh and Dyer, 1959). SatPC was isolated using the
method of Mason et al. (Mason et al., 1976) and quantitated by phos-
phorous measurement. Data were normalized to genomic DNA using
a previously described method (Cesarone et al., 1979).
Total lung glycogen was measured using a modiﬁed method of
Hassid and Abraham (Hassid and Abraham, 1957). Brieﬂy, embryonic
lung tissue was pulse sonicated on ice and boiled for 10 min in
anthrone reagent (0.2% anthrone (cat#AN135, Spectrum Chemical,
Gardena, CA) in 95% sulfuric acid). The samples were then cooled
on ice for 10 min and absorbance was measured at 620nM. Dilutions
of D-glucose, ranging from 0.5 μg to 200 μg, were used to generate the
standard curve. Data were normalized to genomic DNA content using
an aliquot of the sample obtained prior to the glycogen assay.
Real-time PCR analysis
Whole-lung total RNA was puriﬁed by RNeasy Mini Kit (Qiagen, Va-
lencia, CA) and reverse transcribed into cDNA with the iScript kit
(BioRad, Hercules, CA). Quantitative RT-PCR (qPCR) was performed
on a 7300 real-time PCR system (Applied Biosystems, Foster City, CA)
with TaqMan probes (listed in Supplemental Data, Table 1) and nor-
malized to endogenous ActB for control (probe part number
4352933E). qPCR was performed with an n of 3–6 mice for each
genotype.
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Tissues were ﬁxed in 4% paraformaldehyde, embedded in parafﬁn
and 5 μm sections were cut for H&E staining or IHC. Sections were
processed with antigen retrieval using heating in citrate buffer.
Primary antibodies used were: guinea pig anti-HIF1a (1:1000, gener-
ated in this laboratory); mouse anti-ARNT (1:200, cat#611078, BD
Biosciences, Franklin Lakes, NJ); rabbit anti-Prox1 (1:200, cat#20R-
PRO39, Fitzgerald Industries, Acton, MA); mouse anti-HA (1:100,
cat#2367S, Cell Signaling, Danvers, MA); rabbit anti-mature SFTPB,
rabbit anti-pro SFTPC and rabbit anti-ABCA3 (1:500–1:2000, Seven
Hills Bioreagents, Cincinnati, OH); rat anti-CD34 (1:50, cat#ab8158,
Abcam, Cambridge, MA); rabbit anti-phospho histone H3 (pHH3)
(1:500, cat#sc8656r, SCBT, Santa Cruz, CA); rabbit anti-cleaved
Notch1 (Val1744) (1:100, cat#2421, Cell Signaling, Danvers, MA);
goat anti-Flt4 (1:100, cat#AF743, R&D Systems, Minneapolis, MN);
mouse anti-Cdkn1a (1:250, cat#556430, BD Pharmingen, San Diego,
CA). Biotinylated secondary antibodies were used with the ABC
Vectastain kit (Vector Laboratories) for immunohistochemistry, ﬂuo-
rescent secondary antibodies were used for immunoﬂuorescence.
DAB with nickel enhancement was used for mature SFTPB, pro
SFTPC, ABCA3, Prox1, Cdkn1a and HA staining followed by a nuclear
fast red counterstain; DAB was used for HIF1, ARNT, pHH3 and
CD34 with a hematoxylin counterstain.
Mitochondrial DNA assay
Total DNA was extracted from embryonic lung tissue. The amount
of mitochondrial DNA relative to nuclear DNA was determined by
qPCR analysis as described by Zhang et al. (2008) using the following
primers: Nd2 (NADH dehydrogenase subunit 2, mitochondrial
genome): FWD — CCCATTCCACTTCTGATTACC, REV — ATGATAGTA-
GAGTTGAGTAGCG; Nme1 (non-metastatic cells 1, nuclear genome):
FWD — CCTTCTTTACTGGCCTGGTG, REV — CGCACAGCTCTTG-
TACTCCA. Relative ND2 copy number was calculated by the Livak
method, using Nme1 for normalization.
pHH3 morphometry
Cell counts of pHH3-positive cells were obtained by immunohisto-
chemistry. Quantiﬁcation was performed on lung sections from CON
and HIF1a TPMmice (n=4 per group). Approximately 10–12 random
high power ﬁelds were imaged from each animal (4 images per lobe)
with the x- and y-coordinates of the images selected by a random
number generator. The total number of pHH3-positive cells in the ep-
ithelium and the mesenchyme were counted manually and the raw
data for each group were pooled.
Immunoblot analysis
Nuclear extracts were isolated from transfected HeLa cells using
the NE-PER Nuclear Protein Extraction kit (Fisher Scientiﬁc,
Pittsburgh, PA). Protein content was measured using a BCA protein
assay (Fisher Scientiﬁc, Pittsburgh, PA). Nuclear extracts (50 μg)
were separated on 8% PAGEGels (Fisher Scientiﬁc, Pittsburgh, PA)
for HIF1a and HA under reducing conditions. Blots were stripped
and reprobed with anti-TFIIB (1:100, cat#sc-274, SCBT, Santa Cruz,
CA) for loading control. Primary antisera included guinea pig anti-
HIF1a (1:1000, generated in this laboratory), mouse anti-HA
(1:1000, cat#2367S, Cell Signaling, Danvers, MA).
Transmission electron microscopy
The upper right lobes of E18.5 mouse lungs were ﬁxed, processed
and analyzed as previously described (Bridges et al., 2010).Plasmid and luciferase reporter assays
The HRE-luc reporter plasmid was kindly provided by Roland
Wegner (Gassmann et al., 1997). The VEGFp-luc reporter plasmid
was kindly provided by Debabrata Mukhopadhyay (Mukhopadhyay
et al., 1995). Luciferase assays was performed by transfecting HeLa
cells with the HRE-luc/pGL3 or VEGFp-luc plasmid (200 ng) along
with empty vector control plasmid (pcDNA3.1+), HIF1a WT/
pcDNA3.1+, HIF1a ΔODD,N803A/pcDNA3.1+ or HIF1a TPM/
pcDNA3.1+ (50–250 ng) using the transfection reagent Lipofecta-
mine 2000 (Invitrogen, Carlsbad, CA). CMV-βGal plasmid was
cotransfected to serve as an internal control, and luciferase activity
was normalized to β-galactosidase activity after 24 h of transfection.
Isolation and culture of fetal lung mesenchyme
Distal lung mesenchyme was isolated from wild-type FVB/N mice
at E12.5 as previously described (Hyatt et al., 2002). Brieﬂy, distal
lung tips were removed with Moria knives, treated with Dispase for
20 min at 37 °C, rinsed 2× in ice-cold Hanks Buffered Salts+10%
FBS and treated brieﬂy with DNase I. The epithelium was separated
from the mesenchyme with ﬁne tungsten needles. 5–7 pieces of mes-
enchyme were enrobed in 100 μl drops of Cultrex® basement mem-
brane extract (Trevigen, Gaithersburg, MD) and cultured in 10%
DMEM/F12 supplemented with 100 ng/ml recombinant FGF-9
(Peprotech, Rocky Hill, NJ). Recombinant human VEGFA-165 and
VEGFC (Cys156Ser) (R&D Systems, Minneapolis, MN) were added to
the cultures at 20 ng/ml as indicated. The gamma-secretase inhibitor
DAPT (Sigma, St. Louis, MO) was added at 5 μM as indicated.
Isolation and culture of adult type II cells
Mouse alveolar type II cells were isolated from 8-week old HIF1a
TPM and CONmice (n=4 per genotype) and cultured on 100% Cultrex
basementmembrane extract as previously described (Rice et al., 2002).
Cells were cultured for 3 days in BEGM containing 10% FBS and 10 ng/
ml KGF (Peprotech, Rocky Hill, NJ). On the fourth day, doxycycline
(1 μg/ml) was added to the culture medium for 24 h. The cells were
harvested with dispase and processed for qPCR analysis as described.
VEGFA protein measurements
Individual E14.5 lungs were placed in PBS and pulse sonicated on
ice. Total VEGFA protein was determined by ELISA (R&D Systems,
Minneapolis, MN) and standardized to total protein content as deter-
mined by BCA assay.
Statistical analysis
All data are presented as means±SEM with p≤0.05 considered
signiﬁcant. Multiple group comparisons were made by one-way
ANOVA with a Tukey post-hoc analysis. Two-way comparisons were
performed by two-tailed, unpaired Student's t-test. All analyses
were performed using GraphPad Prizm software version 5.0.
Results
Ontogeny of HIF1a, EPAS1, NEPAS and ARNT in the developing mouse
lung
To deﬁne the expression levels and localization patterns of hypox-
ia inducible factor subunits during mouse lung development, mRNA
expression proﬁles in whole lung homogenates were analyzed by
qPCR analysis. HIF1amRNA levels were highest at E11.5 and generally
decreased throughout development (Fig. 1A). In contrast, Epas1 levels
were low from E11.5 through E17.5, increased signiﬁcantly at PN1,
with peak expression observed in adulthood (Fig. 1B). Nepas mRNA
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tectable by PN7 (Fig. 1C), consistent with previous data (Yamashita
et al., 2008). In contrast to the dynamic expression patterns of the
HIF alpha subunits, Arnt mRNA levels were rather steady throughout
prenatal lung development, followed by a 50% decrease at E17.5
through adulthood (Fig. 1D).
We next deﬁned the localization of HIF1a and ARNT protein in
the developing lung by immunohistochemistry. As shown in
Fig. 1E, HIF1a protein was undetectable in the embryonic lung
until E14.5, a stage at which weak nuclear staining was observed
in the developing epithelium (white dotted circles). HIF1a protein
levels were increased in the epithelium at E16.5 and E18.5. HIF1a
protein was not detected in the mesenchyme at any stage of lung
development. In contrast to HIF1a, ARNT protein was readily
detected in both mesenchymal and epithelial cells at E12.5 and
staining intensity steadily increased throughout gestation. Interest-
ingly, ARNT expression was primarily restricted to the epithelial
cells at E18.5.B
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Fig. 1. Ontogeny of Hif1a, Epas1, Nepas and Arnt in the developing mouse lung. A–D) qPCR of
in scale on the graphs for relative expression of the target genes. n=3 lungs per gestational
Note nuclear staining of HIF1a protein in the epithelial cells (white dotted circles) through
mesenchymal and epithelial cells (black dotted circles) throughout gestation. Scale bar=5Epithelial expression of HIF1a ΔODD,N803A during lung development
results in perinatal lethality
To further deﬁne the role of HIF1a signaling during lung develop-
ment, we generated transgenic mice that conditionally expressed a
normoxia stable form of HIF1a in the pulmonary epithelium (TRE-
HIF1a ΔODD,N803A) (Fig. 2A). The HIF1a ΔODD,N803A construct
was engineered by deleting the oxygen-dependent degradation do-
main (ODD, amino acids 401–603) from the human HIF1a cDNA in
order to prevent hydroxylation by the prolylhydroxylase PHD2,
thereby circumventing proteasomal degradation of the ΔODD protein
and promoting stabilization in normoxia as previously described
(Elson et al., 2001; Huang et al., 1998). In addition, the conserved as-
paragine at position 803 was mutated to alanine to prevent hydroxyl-
ation by factor inhibiting HIF (FIH), leading to enhanced
transcriptional activity of the protein in normoxic conditions (Lando
et al., 2002a,b). The completed ΔODD,N803A transgene was then
placed under control of the tetracycline-responsive element (TRE)Epas1
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whole mouse lung for Hif1a, Epas1, Nepas and Arnt from E11.5 to adult. Note differences
age. *pb0.05 vs. E11.5. E) Immunostaining for HIF1a and ARNT in the developing lung.
out gestation, with highest levels observed at E18.5. ARNT protein is detected in both
0 μm.
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were generated using standard methodologies.
To determine the effects of expressing a stabilized form of HIF1a in
the developing pulmonary epithelium, TRE-HIF1a ΔODD,N803A mice
were mated with Sftpc-rtTA activator mice and placed on doxycycline
from E6.5 to birth. A total of 67 newborn pups were obtained from
these crosses, 25 of which were double transgenic for the Sftpc-rtTA
and TRE-HIF1a ΔODD,N803A transgenes (37%). Of these 25 animals,
21 (84%) were either found dead at birth or succumbed shortly there-
after, exhibiting classical signs of respiratory distress including cyano-
sis and labored breathing. Histological analyses of lung tissue from
mice that died shortly after birth revealed the presence of proteina-
ceous material in the airspaces and decreased mesenchymal thinning,
pathological abnormalities that are also consistent with severe respi-
ratory distress and atelectasis (Fig. 2B). Analysis of lung tissue atFig. 2. Epithelial expression of HIF1a ΔODD,N803A during lung development results in perin
transgene was placed under the control of the tetracycline-responsive element (TRE) and tr
trol animals (CON) or bi-transgenic hSftpc-rtTA/TRE HIF1a ΔODD,N803A (ΔODD,N803A) on
of ΔODD,N803A lungs at E18.5 and decreased mesenchymal thinning and airspace debris in
distal epithelial marker expression in CON and ΔODD,N803A animals at E18.5. Note the
surfactant-associated proteins, SFTPB, SFTPC and ABCA3, in ΔODD,N803A vs. CON lungs.
N803A lungs vs. CON at E18.5. n=6 samples per genotype. *pb0.05 vs. CON. E) Gene expr
transporters Slc2a1 and Slc2a3, as well as Pgk1, Car9 and Hk2 in ΔODD,N803A lungs vs. CONE18.5, one day prior to birth, demonstrated no aberrant histological
abnormalities in ΔODD,N803A mice compared to controls.
To determine if the observed phenotype could be attributed to de-
creased or arrested maturation of the distal epithelium, multiple
markers of distal epithelial cell maturation were analyzed. Immuno-
histochemical analyses demonstrated widespread expression of the
ΔODD,N803A transgene in pulmonary epithelial cells, as determined
by HA staining (Fig. 2C). Expression of mature surfactant protein B
(SFTPB), pro-surfactant protein C (SFTPC) and the phospholipid
transporter ATP-binding cassette subfamily A member 3 (ABCA3)
were all decreased in ΔODD,N803A animals compared to controls
(Fig. 2C). Furthermore, total saturated phosphatidylcholine (SatPC),
the primary surface active component of pulmonary surfactant, was
decreased 21% compared to littermate controls (Fig. 2D). qPCR ana-
lyses demonstrated that several known HIF1a target genes wereatal lethality. A) Diagram of the HIF1a ΔODD,N803A transgene. The HIF1a ΔODD,N803A
ansgenic animals were generated. B) H&E staining of lungs from single transgenic con-
dox from E6.5 until harvest at E18.5 or postnatal day 1 (PN1). Note normal morphology
ΔODD,N803A lungs at PN1 compared to controls. C) Immunohistochemical analyses of
nuclear staining of the HA-tagged transgenic protein and the overall decrease of the
D) Saturated phosphatidylcholine (SatPC) levels were slightly decreased in ΔODD,
ession in E14.5 ΔODD,N803A and CON lungs. Note increased expression of the glucose
. n=3–6 samples per genotype. *pb0.05 vs. CON.
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porters Slc2a1 and Slc2a3, and the glycolytic enzymes Pgk1, Car9,
and Hk2 (Fig. 2E). Two additional HIF1 targets, Serpine1 and Vegfa,
were not signiﬁcantly induced by epithelial ΔODD,N803A
expression. Taken together, these data demonstrate that epithelial
expression of the HIF1a ΔODD,N803A protein in the developing
lung results in severe respiratory distress in a majority of the animals
at birth. This pathophysiological phenotype is associated with the
transcriptional activation of a glycolytic program and arrested epithe-
lial maturation, as evidenced by decreased expression of several distal
epithelial markers, including mature SFTPB, pro SFTPC and ABCA3,
and decreased levels of SatPC.
HIF1a triple point mutant (TPM) stability and transactivation potential
compared to ΔODD,N803A
While the ΔODD,N803A protein is more stable and transcription-
ally active in normoxia compared to the wild type protein, we hy-
pothesized that deletion of the 202 amino acid ODD domain from
HIF1a may result in a misfolded protein that could negatively im-
pact cell function. Therefore, as an alternative approach to the
ΔODD,N803A construct, we generated a second stable HIF1a isoform
by speciﬁcally mutating the proline residues that confer degradation
of HIF1a in normoxia, P402 and P564, and asparagine 803 to alanine.
This resultant construct is referred to as HIF1a triple point mutant
(TPM) (Fig. 4A) and is identical to the previously reported P1P2N
HIF1a and HIF1a PPN constructs (Bekeredjian et al., 2010; Dioum
et al., 2008). To distinguish the transfected proteins from endoge-
nous HIF1a, all three constructs (wild type (WT), ΔODD,N803A
and TPM) contained an in-frame, C-terminal HA tag.
The relative stability and transactivation potential of the two sta-
bilized isoforms, HIF1a ΔODD,N803A and HIF1a TPM, were compared
to HIF1a WT by immunoblot analysis of nuclear extracts from tran-
siently transfected HeLa cells cultured under normoxic and hypoxic
(1%O2) conditions for 17 h (Fig. 3). As shown in Fig. 3A, HIF1a TPM
is more stable in normoxia than the WT and ΔODD,N803A isoforms
(compare lane 7 vs. lanes 3 and 5, HIF1a blots). In addition, the TPM
protein is hypoxia-insensitive (lanes 7 vs. 8, HA blot), similar to the
ΔODD,N803A isoform (lanes 5 vs. 6, ΔODD,N803A band in HIF1a
blots). Surprisingly, expression of the ΔODD,N803A isoform inhibited
the hypoxic induction of endogenous HIF1a in HeLa cells (compare
lanes 5 and 6 to lanes 1 and 2, HIF1a band in HIF1a blots).
Transient transactivation assays using two HIF responsive promot-
er constructs, hypoxia responsive element (HRE) HRE-luciferase and
the proximal promoter of the human VEGF gene (VEGFp) VEGFp-
luciferase, demonstrated that the activity of the TPM isoform was 7-
fold higher than WT and 4-fold higher than ΔODD,N803A (Fig. 3B).
In addition, co-transfection of ARNT with the HIF1a constructs poten-
tiated the transactivation response of all isoforms ~3 fold on the HRE-
luciferase and VEGFp-luciferase promoters, demonstrating that ARNT
availability may be limiting, depending on the cell type (Fig. 3C).
Epithelial expression of HIF1a TPM during lung development perturbs
lung morphogenesis and distal epithelial cell maturation
Based on the in vitro expression data demonstrating increased sta-
bility and transactivation potential of the HIF1a TPM, we generated
conditional HIF1a TPM transgenic mice (TRE-HIF1a TPM) (Fig. 4A).
Since the pulmonary epithelium expresses HIF1a, EPAS1 and NEPAS,
all of which dimerize with ARNT, the HIF1a TPM construct was also
engineered to contain an IRES sequence that allowed expression of
a FLAG-tagged ARNT cDNA downstream of HIF1a TPM. Using this
strategy, HIF1a TPM and ARNT protein are generated in a 1:1 ratio
from a single mRNA transcript, thereby preventing HIF1a TPM from
acting as a sink for endogenous ARNT protein, avoiding a possibledominant negative effect on endogenous HIF1a, EPAS1 and/or
NEPAS function.
HIF1a TPM protein was expressed in the embryonic pulmonary
epithelium by mating TRE-HIF1a TPM mice to Sftpc-rtTA mice and
placing the pregnant dams on doxycycline chow from E6.5 until
harvest at E18.5. As shown in Fig. 4B, expression of HIF1a TPM dis-
rupted branching morphogenesis, resulting in large dilated cysts in
the peripheral lung at E18.5. Single transgenic (Sftpc-rtTA or TRE-
HIF1a TPM) or wild-type littermates did not exhibit any morpholog-
ical abnormalities and were used interchangeably as controls (CON).
Histological analysis demonstrated the presence of hypertrophic
cells in the distal epithelium and eosin-positive proteinaceous mate-
rial ﬁlling the primitive air sacs in HIF1a TPM lungs, indicative of
vascular leak (Fig. 4C, H&E). Interestingly, only a small percentage
of epithelial cells stained positively for HA and HIF1a protein in
the HIF1a TPM lungs at this stage, suggesting that the transgene
was either extinguished by the time of analysis, or that transgene-
positive cells underwent apoptosis or necrosis. Staining for cleaved
caspase 3 was negative in HIF1a TPM lungs at this stage and nuclear
morphology of the epithelium was normal as assessed by Hoechst
staining, indicating that the low number of HIF1a TPM-positive
cells was not due to apoptosis or necrosis (data not shown). To
determine if epithelial maturation was altered, pro SFTPC immuno-
histochemistry was performed. The results indicated that pro
SFTPC protein expression was drastically reduced in the HIF1a
TPM epithelium compared to controls, suggesting impaired expan-
sion or maturation of this lineage (Fig. 4C, pro SFTPC). Consistent
with these ﬁndings, qPCR analysis demonstrated a 25–50% decrease
in four markers of distal epithelial cell maturation including Pdpn,
Lpcat1, Sftpb and Sftpc (Fig. 4D). Since the HIF1a TPM transgene
was driven from the Sftpc promoter in this experiment, the most
likely explanation for the low number of transgene-positive cells
was decreased SFTPC expression.
To further characterize the maturational state of the pulmonary
epithelium in HIF1a TPM mice, lungs were processed for electron mi-
croscopy. Toluidine blue-stained, semi-thin sections and electron mi-
crographs showed abundant secreted surfactant in the airspaces of
CON lungs at E18.5 (Figs. 5A and C, arrows). In addition, alveolar
type II cells of CON animals contained numerous mature lamellar
bodies and minimal glycogen stores (Fig. 5C, arrowheads). In con-
trast, the airspaces of HIF1a TPMmice were devoid of secreted surfac-
tant (Fig. 5B) and mature lamellar bodies were absent in the distal
epithelial cells. Instead, abundant glycogen stores were readily ob-
served in HIF1a TPM epithelial cells, consistent with impaired matu-
ration. Glycogen assays on E18.5 lungs demonstrated a 2.1-fold
increase in total lung glycogen in HIF1a TPM lungs (Fig. 5E). Since gly-
cogen serves as the substrate for surfactant phospholipid biosynthe-
sis, it was not surprising that the lack of depletion of glycogen was
accompanied by a concomitant 2.3-fold decrease in tissue SatPC
levels (Fig. 5F). Collectively, these data indicate that continuous
HIF1a TPM expression in the developing epithelium impairs distal ep-
ithelial cell maturation, resulting in severe dysmorphogenesis at
E18.5.
Defective branching morphogenesis, hemorrhaging and induction of a
glycolytic switch in HIF1a TPM lungs at E14.5
To determine the time point at which epithelial HIF1a TPM ex-
pression ﬁrst induces lung dysmorphogenesis, the HIF1a TPM trans-
gene was activated in utero from E6.5 until harvest at E12.5 or
E14.5. Branching morphogenesis was unaltered in lungs that
expressed HIF1a TPM from E6.5 to E12.5 (n=6–8 per genotype,
data not shown). In contrast, severe defects were noted in the
HIF1a TPM lungs at E14.5 including overall hypoplasia, decreased
branching of the developing airways and prominent subpleural
hemorrhaging (Fig. 6A). In contrast to the mosaic expression pattern
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30 J.P. Bridges et al. / Developmental Biology 362 (2012) 24–41of the transgene at E18.5 (Fig. 4C), HIF1a TPM protein was readily
detected in a majority of epithelial cells at E14.5, as seen by anti-
HA and anti-HIF1a immunohistochemistry (Fig. 6B). Increased
ARNT protein was also detected in the epithelial cells of HIF1aTPM mice, indicating expression of the ARNT transgene (Fig. 6B,
ARNT staining, arrowheads).
HIF1a expression has been shown to inhibit energy-expensive
processes such as cell proliferation, thereby preserving adequate
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31J.P. Bridges et al. / Developmental Biology 362 (2012) 24–41ATP levels to ensure cell survival (Chandel, 2010). To determine if
HIF1a expression inhibited epithelial cell proliferation in HIF1a TPM
mice, phospho-histone H3 (pHH3) staining was performed on E14.5
lung sections. As shown in Figs. 7A and B, pHH3 staining was signiﬁ-
cantly decreased in the epithelium of HIF1a TPM lungs but not in the
mesenchymal cell compartment. HIF1a has been shown to inhibit cell
cycle progression via increased expression of Cdkn1a (Koshiji et al.,
2004). Therefore, we examined the expression of the cell cycle inhib-
itors Cdkn1a and Cdkn1b in HIF1a TPM lungs at E14.5. Cdkn1a mRNA
was increased 2.9-fold in HIF1a TPM lungs while Cdkn1b levels re-
main unchanged (Fig. 7C). In accordance, Cdkn1a protein was highly
induced in the epithelium of HIF1a TPM mice (Fig. 7D). Both Cdkn1a
and Cdkn1b levels were unchanged in HIF1a ΔODD,N803A at E14.5
(Supplemental Fig. 2). These data suggest that the hypoplastic and
impaired branching phenotype is due, in part, to an inhibition ofcell cycle progression in the developing epithelium of HIF1a TPM
mice.
H&E staining of E14.5 lungs revealed the presence of hypertrophic
epithelial cells that stained negatively for eosin (Fig. 8A), similar to
what was observed when the transgene was expressed from E6.5 to
E18.5 (Fig. 4C). Accordingly, total lung glycogen content was found
to be increased 2.5-fold in HIF1a TPM lungs (Fig. 8B). The increased
glycogen content at this stage of development suggested that HIF1a
TPM expression in the developing epithelial cells induced a metabolic
shift toward a glycolytic phenotype, a known HIF1a-dependent event
(Iyer et al., 1998). To test this hypothesis, glycolytic enzymes that are
known HIF1a targets were measured in HIF1a TPM lungs by qPCR
analysis. HIF1a TPM induced the expression of several glycolytic
genes including Aldoc, Slc2a1, Slc2a3, Pdk1 and Pgk1 (Fig. 8C). Inter-
estingly, expression of Bhlhe40, a transcription factor with known
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2002), was induced 3.5-fold in HIF1a TPM lungs.
Given the known role of HIF1a in regulating mitochondrial ho-
meostasis (Zhang et al., 2007, 2008), the total mitochondrial content
of HIF1a TPM lungs was measured and compared to CON lungs. Sur-
prisingly, the mitochondrial content of HIF1a TPM lungs was de-
creased 3.2-fold compared to CON lungs (Fig. 8D). In addition, the
mRNA levels of the cytochrome oxidase C subunit 4i2 gene (Cox4i2),
a known HIF1a target that optimizes ﬂux through the electron trans-
port chain and minimizes the generation of reactive oxygen species
under hypoxic conditions (Fukuda et al., 2007), were also increased
3.0-fold in HIF1a TPM lungs (Fig. 8E). Taken together, these data dem-
onstrate that HIF1a TPM expression in the pulmonary epithelium in-
duced a metabolic shift toward a glycolytic phenotype, as evidenced
by induction of several glycolytic enzymes, a net increase in glycogen
content, decreased mitochondrial content and Cox4 subunit
switching.
Compromised vascular integrity in HIF1a TPM embryonic lungs
The basis for the subpleural hemorrhaging observed in E14.5
HIF1a TPM lungs (Fig. 6A) was explored in further histological detail.
The blood pooling was primarily subpleural in nature, localized to thearea immediately subtending the lung mesothelium (Fig. 9A, arrow-
heads). To determine if vascular patterning was grossly disrupted
by epithelial HIF1a TPM expression, the Tek-lacZ allele was crossed
into the HIF1a TPM and CON mice. The Tek-lacZ transgene is a pan-
endothelial marker expressed on arterial, venous and lymphatic en-
dothelial cells, and therefore serves as a robust tool to visualize
vascular development (Schlaeger et al., 1997). Whole mount β-
galactosidase assays of Tek-lacZ/HIF1a TPM and Tek-lacZ/CON lungs
indicated that global vascular patterning was normal in HIF1a TPM
lungs at E14.5, including appropriate formation of the vascular plexus
enrobing the developing epithelial buds (Fig. 9A, Tek-lacZ). To further
conﬁrm normal patterning of the vasculature, CD34 immunohisto-
chemistry was performed on parafﬁn-embedded sections. In concor-
dance with the Tek-lacZ data, the association of CD34-positive
endothelium with the surrounding epithelium was not grossly per-
turbed in HIF1a TPM lungs (Fig. 9A, CD34 insets). While the overall
density of CD34-positive staining appeared to be decreased in HIF1a
TPM lungs, the degree of staining correlated with the decreased num-
ber of epithelial buds. These data suggested that the subpleural
hemorrhaging was due to compromised endothelial barrier function
as opposed to defects in patterning of the pulmonary vasculature.
Given that VEGFA is a direct transcriptional target of HIF1a and has
known vessel permeability-promoting properties, we measured the
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Fig. 6. Defective branching morphogenesis and hemorrhaging in HIF1a TPM lungs at E14.5. A) Gross views of lungs from individual CON and HIF1a TPM littermates on dox from E6.5
until harvest at E14.5. Note branching defects as evidenced by large cysts in distal airways, overall hypoplasia of lung tissue and subpleural hemorrhaging in HIF1a TPM lungs vs.
CON. B) Immunostaining of HIF1a TPM lungs vs. CON at E14.5. The HIF1a TPM transgene is abundantly expressed in the distal lung epithelium of HIF1a TPM lungs as detected by
anti-HA and anti-HIF1a antibodies. Note increased staining of ARNT in distal epithelial cells of HIF1a TPM lungs (arrowheads), indicating expression of the ARNT transgene. Scale
bars=100 μm.
33J.P. Bridges et al. / Developmental Biology 362 (2012) 24–41levels of Vegfa isoforms in HIF1a TPM lungs by qPCR analysis. Signiﬁ-
cant increases in the Vegfa164 and Vegfa188 isoforms were observed, as
was a modest increase in the lymphangiogenic promoting VEGF fam-
ily member, Vegfc (Fig. 9B). The increased Vegfa mRNA levels in the
HIF1a TPM lungs correlated with a 2.2-fold increase of total VEGFA
protein levels in whole lung homogenate (Fig. 9C). To determine if
HIF1a TPM-dependent increases in Vegfa and Vegfc were cell autono-
mous, type II epithelial cells were isolated from adult HIF1a TPM and
CON animals that had not been exposed to dox in vivo and cultured in
vitro. Activation of HIF1a TPM in isolated type II epithelial cells in-
duced Vegfa and Vegfc mRNA to levels that were higher than that
seen in whole lung homogenates, demonstrating that HIF1a induces
these genes in the epithelium (Fig. 9D). Of note, VEGFA protein levels
in lung homogenates of E14.5 HIF1a ΔODD,N803A mice did not differ
from littermate controls, consistent with the lack of a hemorrhagic
phenotype in this model (Supplementary Fig. 1B). Collectively,
HIF1a TPM expression increases VEGFA and VEGFC expression in
type II cells of HIF1a TPM mice and while gross vascular patterning
is unaffected in these animals, endothelial barrier function appears
to be disrupted as evidenced by profound subpleural hemorrhaging.
Epithelial expression of HIF1a TPM induces lymphangiogenesis in the
embryonic lung
Based on the observation that HIF1a TPM expression induced
Vegfc transcription, we next determined if lymphangiogenesis was in-
creased in HIF1a TPM lungs at E14.5. As an initial index, we quantiﬁed
a panel of lymphangiogenic markers in HIF1a TPM lungs and found
that the transcription factors Prox1, Foxc2, Sox17 and Sox18 were allincreased in HIF1a TPM lungs, in addition to Ccl21a, a chemokine
that is produced by lymphatic endothelial cells (Fig. 10A) (Bromley
et al., 2005). These ﬁndings were supported by Prox1 immunohisto-
chemistry data, which demonstrated an increased number of Prox1-
positive endothelial cells in HIF1a TPM pulmonary vessels compared
to CON (Figs. 10C vs. B, arrows in insets). Since Prox1 is also expressed
in pulmonary neuroendocrine cells at this stage of development
(Figs. 10B and C, arrowheads in insets), dual immunoﬂuorescence
for Prox1 and FLT4 was performed to denote deﬁnitive lymphatic ves-
sels. Note the dramatic increase in the number and size of dual-
positive lymphatic vessels in the HIF1a TPM lungs compared to CON
(Figs. 10E vs. D, arrowheads).
Due to the known role of Notch signaling in blood vessel speciﬁca-
tion, we measured the expression of a number of Notch pathway
components in HIF1a TPM lungs and found that two of the four
Notch receptors, Notch3 and Notch4, were modestly increased, as
was the Notch ligand Jag1. In addition, three downstream Notch ef-
fectors, Hey1, Hey2 and Heyl, were also increased (Fig. 10F). We also
measured the expression of Notch signaling components in HIF1a
ΔODD,N803A mice at E14.5 (Supplementary Fig. 1A). Both the reper-
toire and extent of induction differed between the HIF1a TPM and
ΔODD,N803A lungs. Speciﬁcally, in HIF1a ΔODD,N803A lungs the re-
ceptors Notch1 and Notch4 were induced, as were the effectors Hey1
and Heyl, while Notch3, Jag1 and Hey2 levels remained unchanged.
HIF1a is known to potentiate Notch1 signaling through direct pro-
tein–protein interactions with the Notch1 intercellular domain
(NICD) (Gustafsson et al., 2005; Sahlgren et al., 2008). To discern
whether HIF1a TPM expression was directly potentiating Notch1 sig-
naling in the epithelium, immunoﬂuorescent staining was performed
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34 J.P. Bridges et al. / Developmental Biology 362 (2012) 24–41with the Notch1 Val1744 antibody as a readout for active Notch1 sig-
naling (Del Monte et al., 2007). As shown in Fig. 10G, active Notch1
signaling was not detected in the epithelium of E14.5 control mice,
consistent with previous data (Morimoto et al., 2010), and HIF1a
TPM expression did not induce Notch1 signaling in the epithelium.
However, HIF1a TPM expression did increase the basal Notch1
Val1744 staining seen in the mesenchyme immediately subtending
the epithelium of CON lungs (Fig. 10G, arrows), indicating that epi-
thelial HIF1a expression indirectly activates Notch1 signaling in mes-
enchymal cells.
VEGFA and VEGFC are sufﬁcient to induce Notch-dependent activation of
lymphangiogenic markers in fetal lung mesenchyme
In order to determine if VEGFA and VEGFC were sufﬁcient to in-
duce lymphangiogenic markers in lung mesenchymal cells indepen-
dent of lung epithelium, fetal lung mesenchyme was isolated from
E12.5 mouse lungs and cultured on basement membrane extract in
the presence of exogenous FGF9 to promote survival and expansion
of this tissue in culture (del Moral et al., 2006; White et al., 2006)
(Fig. 11A). Recombinant human VEGFA-165 or the FLT4-speciﬁc
VEGFC protein, VEGFC(Cys156Ser), was added to the mesenchyme
cultures on d2 in the presence or absence of the Notch inhibitor
DAPT. The mesenchyme was then harvested on d3 for qPCR analysis
of lymphangiogenesis markers and Notch pathway components. As
shown in Fig. 11B, both exogenous VEGFA-165 and VEGFC(Cys156-
Ser) protein induced expression of the lymphangiogenic transcription
factors Foxc2 and Sox18 while expression of Prox1 was not affected.
The Notch pathway downstream effector genes shown to be induced
in HIF1a TPM lungs, Hey1 and Heyl, were also induced by exogenous
VEGFA or VEGFC-treated isolated mesenchyme. Interestingly, both
VEGFA- and VEGFC-induced upregulation of Foxc2, Sox18, Hey1 andHeyl were completely suppressed by co-treatment with the Notch
pathway inhibitor, DAPT (Fig. 11B). Collectively, these data are con-
sistent with a model in which activation of epithelial HIF1a protein
leads to increased expression and secretion of VEGFA and VEGFC
from the pulmonary epithelium (Fig. 11C). The secreted VEGFA and
VEGFC ligands then engage their cognate receptors, KDR and FLT4 re-
spectively, on neighboring endothelial precursor cells, leading to the
downstream activation of Notch signaling on adjacent endothelial
cells. This activation of Notch receptors then leads to the induction
of a lymphangiogenic pathway, as evidenced by increased expression
of Sox18, Foxc2, Hey1 and Heyl.
Discussion
Our goal in this study was to further deﬁne the role of HIF1a in the
pulmonary epithelium during lung organogenesis. Our data demon-
strate that endogenous expression of HIF1a protein is primarily re-
stricted to epithelial cells in the developing murine lung, with
expression ﬁrst detected at E14.5; in contrast, expression of ARNT,
the obligate transcriptional binding partner of HIF1a, was detected
in both mesenchymal and epithelial cells at E12.5 and expression
was maintained throughout lung development. Transgenic expres-
sion of a normoxia-stable and transcriptionally-enhanced isoform of
HIF1a, HIF1a ΔODD,N803A, in the developing epithelium did not im-
pair branching morphogenesis, but instead resulted in respiratory
distress and signiﬁcant lethality at birth. The impaired respiratory
phenotype in HIF1a ΔODD,N803A mice was associated with reduced
SatPC content and decreased expression of several genes that are crit-
ical for surfactant production and function, including Sftpc, Sftpb and
Abca3. In contrast, transgenic expression of an alternative normoxia-
stable, transcriptionally-enhanced HIF1a isoform, HIF1a TPM, in
the epithelium drastically disrupted branching morphogenesis,
010
20
30
gl
yc
og
en
/D
NA
( μg
/μ
g)
CON HIF1a
TPM
*
D
0.00
0.25
0.50
0.75
1.00
1.25
E
CON HIF1a
TPM
HIF1a
TPM
*
m
ito
ch
on
dr
ia
l D
NA
0
1
2
3
4
5
CON
Cox4i2
*
fo
ld
 in
cr
ea
se
Aldoc Ldha
HIF1a TPM
CON
Slc2a1 Slc2a3 Pdk1 Pgk1
*
*
*
* *fo
ld
 in
cr
ea
se
0
1
2
3
4
5
5
10
15
20
25
30
Bhlhe40
*
*
CON
HIF1a
TPM
A B
C
Fig. 8. Epithelial expression of HIF1a TPM induces a glycolytic switch in embryonic distal epithelial cells. A) H&E staining reveals cystic airways and hypertrophic epithelial cells in
HIF1a TPM lungs on dox from E6.5 until harvest at E14.5. B) Glycogen assays demonstrate increased glycogen stores in HIF1a TPM lungs at E14.5 vs. CON. Total glycogen content was
normalized to genomic DNA. n=3–6 samples per genotype. *pb0.05 vs. CON. C) HIF1a TPM lungs show increased transcriptional expression of glucose transporters (Slc2a1,
Slc2a3), glycolytic enzymes (Aldoc, Pdk1, Pgk1) and a gene known to inhibit apoptosis and promote HIF1a-dependent repression of lipogenesis (Bhlhe40). n=3–6 samples per ge-
notype. *pb0.05 vs. CON. D) Mitochondrial content from whole lung homogenates was decreased in HIF1a TPM lungs. n=4 samples per genotype. *pb0.05 vs. CON. E) qPCR anal-
ysis indicating that HIF1a TPM lungs have increased expression of cytochrome c oxidase subunit IV isoform 2. n=6 samples per genotype. *pb0.05 vs. CON.
35J.P. Bridges et al. / Developmental Biology 362 (2012) 24–41associated with decreased epithelial proliferation, a metabolic shift
toward a glycolytic phenotype and impaired epithelial maturation.
Moreover, HIF1a TPM expression resulted in pulmonary vascular ab-
normalities, including subpleural hemorrhaging and a marked in-
crease in lymphangiogenesis. These phenotypes were associated
with increased VEGFA and VEGFC production and activation of
Notch signaling pathways. Collectively, these data indicate that ex-
cessive HIF1a activation in the fetal pulmonary epithelium results in
developmental and maturational defects, suggesting that conditions
that promote epithelial HIF1a stability and activation in utero may
negatively impact pulmonary development and function.
Previous work from our lab has shown that the threshold level of
SatPC required for perinatal lung function in mice lies between 4.3
and 5.6 nmol/mg tissue weight, amounts that represent 46.0–60.0%
of wild-type levels (Bridges et al., 2010). Based on these data, it is un-
likely that the 21% decrease in SatPC levels seen in HIF1a ΔODD,
N803A mice solely underlies the respiratory distress and neonatal le-
thal phenotype. However, this deﬁciency in SatPC production, com-
bined with substantial decreases in mature SFTPB and ABCA3
protein expression, both of which are required for the transition toair breathing (Ban et al., 2007; Clark et al., 1995; Fitzgerald et al.,
2007; Hammel et al., 2007), may have been sufﬁcient to induce respi-
ratory distress at birth. We do not believe that the HIF1a-mediated in-
hibition of SFTPB and ABCA3 expression is direct, since HIF1a TPM
expression did not suppress baseline expression of the proximal
Sftpb and Abca3 promoters in luciferase reporter assays (data not
shown). An alternative explanation for the observed phenotype is
that the HIF1a ΔODD,N803A protein inhibited endogenous HIF1a
function in the developing respiratory epithelium of HIF1a ΔODD,
N803A transgenic mice. This possibility stems from our observation
that transient HIF1a ΔODD,N803A expression in HeLa cells decreased
the hypoxic induction of endogenous HIF1a protein (Fig. 3A). In sup-
port of this hypothesis, genetic deletion of HIF1a in the developing re-
spiratory epithelium resulted in phenotypic similarities seen in HIF1a
ΔODD,N803A mice, including decreased production of surfactant pro-
teins SFTPB and SFTPC and the phospholipid transporter ABCA3 in
distal epithelial cells without defects in branching morphogenesis
(Saini et al., 2008).
Epithelial HIF1a TPM expression profoundly affected branching
morphogenesis, characterized by hypoplasia and the presence of a
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36 J.P. Bridges et al. / Developmental Biology 362 (2012) 24–41cystic distal epithelium that was initially detected at E14.5 and per-
sisted throughout lung organogenesis. One possible explanation for
this morphogenetic defect is decreased proliferation of HIF1a TPM-
expressing epithelial cells (Figs. 7A and B). During early embryonic
lung development, the rate of cell proliferation is highest in the ep-
ithelial cells located at the branch points where it drives both
growth and patterning of the developing airways (Hogan and
Yingling, 1998; Warburton et al., 2000). In vitro studies have
shown that prolonged hypoxic exposure induces HIF1a-dependent
cell cycle arrest in a variety of cell types (Gardner et al., 2001;
Goda et al., 2003; Green et al., 2001; Koshiji et al., 2004). Arrest oc-
curs at the G1/S transition and is driven by increased expression of
the cell cycle regulators Cdkn1a, via HIF1a-mediated displacement of
the C-Myc repressor from the Cdkn1a promoter, and direct tran-
scriptional activation of Cdkn1b (Gardner et al., 2001; Goda et al.,2003). In the HIF1a TPM transgenic mice, Cdkn1a was induced in
the epithelium whereas Cdkn1b levels were unchanged (Figs. 7C
and D). Importantly, both Cdkn1a and Cdkn1b levels were not in-
duced in HIF1a ΔODD,N803A mice (Supplementary Fig. 2), in
which branching proceeded normally, suggesting that the differen-
tial transcriptional induction of Cdkn1a in HIF1a TPM mice underlies
the branching defect. In addition to the induction of Cdkn1a, it is
likely that the decreased mitochondrial content and metabolic
shunting toward glycolysis also contributed to decreased epithelial
proliferation by limiting the amount of ATP required for this energy
expensive process. Interestingly, genetic deletion of another Myc
family member, N-Myc, resulted in a similar cystic phenotype that
was associated with decreased epithelial cell proliferation (Moens
et al., 1992; Moens et al., 1993; Okubo et al., 2005; Sawai et al.,
1993). Whether the decreased proliferation observed in the HIF1a
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37J.P. Bridges et al. / Developmental Biology 362 (2012) 24–41TPM respiratory epithelium is also due, in part, to an N-Myc-
dependent mechanism remains to be determined.
The blood vascular defects in HIF1a TPM lungs did not appear to
be due to hypervascularity or gross alterations in patterning of the
vascular plexus. One possible explanation for the subpleural
hemorrhaging is the HIF1a-mediated induction of endogenous
VEGFA protein from the epithelial cells, resulting in increased perme-
ability of the blood vasculature. This hypothesis is consistent with
previous reports demonstrating an accumulation of interstitial ﬂuid
in transgenic mice that overexpressed the mouse VEGFA164 isoform
in developing (Zeng et al., 1998) or postnatal (Le Cras et al., 2004)
pulmonary epithelial cells, and in adult lungs in which human
VEGF-165 was ectopically expressed by adenoviral infection (Kaner
et al., 2000). In addition, HIF1a ΔODD,N803A mice, in which blood
vascular integrity was normal, did not have elevated VEGFA levels
(Supplemental Fig. 1A). Gain of HIF1a function in the epidermis,
using two distinct HIF1a transgenic constructs and epidermalpromoters, increased endogenous VEGFA levels and was associated
with a vascular phenotype that was distinct from our model, charac-
terized by hypervascularity in the absence of baseline microvascular
leak (Elson et al., 2001; Oladipupo et al., 2011). Manymechanistic dif-
ferences could be responsible for the discrepancy between the HIF1a-
mediated phenotype in the pulmonary and epidermal vascular tissue
beds including: 1) potency of HIF1a transgenic constructs; 2) differ-
ential VEGF receptor expression on endothelial cells in the developing
lung compared to the epidermis; 3) differences in VEGFA isoform ex-
pression between the models or 4) dysregulation of alternative path-
ways that modulate vascular permeability independent of VEGFA.
Determining the mechanistic basis underlying the sensitivity of
the pulmonary microvasculature to HIF1a-mediated permeability
requires further investigation.
The increased lymphangiogenesis in the HIF1a TPM mice was a
surprising observation. Previous data had shown that conditional in-
duction of the VEGFA164 isoform in the pulmonary epithelium during
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38 J.P. Bridges et al. / Developmental Biology 362 (2012) 24–41the pseudoglandular stage of development was sufﬁcient to induce a
3-fold increase in lymphangiogenesis (Mallory et al., 2006). In our
model, HIF1a TPM induced expression of VEGFA164, but also increased
expression of the VEGFA188 isoform and another VEGF family mem-
ber, VEGFC, a bona ﬁde lymphangiogenic growth factor (Karkkainen
et al., 2004; Lohela et al., 2008). Furthermore, we observed activation
of Notch1 signaling in the lung mesenchyme and induction of several
Notch pathway components that are known modulators of blood andlymphatic endothelial cell speciﬁcation (Figs. 10F and G, see (Rocha
and Adams, 2009) for review). Ex vivo experiments using
epithelium-free fetal lung mesenchyme demonstrated that recombi-
nant VEGFA-165 and VEGFC were independently sufﬁcient to induce
the Notch effectors Hey1 and Heyl, and the lymphatic markers Foxc2
and Sox18, but not Prox1 (Fig. 11B). In addition, induction of these
lymphatic markers by VEGFA or VEGFC was prevented by co-
treatment of the mesenchyme with the Notch inhibitor DAPT.
39J.P. Bridges et al. / Developmental Biology 362 (2012) 24–41Collectively, these data suggest a model whereby HIF1a TPM-
mediated lymphangiogenesis is mediated by increased VEGFA and/
or VEGFC secretion by the epithelium, engaging the KDR and/or
FLT4 receptors on endothelial precursor cells in the fetal lung mesen-
chyme. KDR and/or FLT4 engagement then activates Notch signaling
in an adjacent endothelial precursor cell to govern it toward a lym-
phatic endothelial cell fate (Fig. 11C).
Fetal lung development occurs in a relatively hypoxic environ-
ment (Gao and Raj, 2010), suggesting that low oxygen tension pro-
motes organogenesis. Consistent with this concept, ex vivo studies
performed with rodent lung explants demonstrate that both airway
branching and vascular morphogenesis are increased when cultured
in a hypoxic environment (Gebb and Jones, 2003; Gebb et al., 2005;
van Tuyl et al., 2005). Using an oligodeoxynucleotide knockdown
approach, Van Tuyl et al. demonstrated that the hypoxia-mediated
increase in branching and vascular morphogenesis observed in
their model were mediated by HIF1a (van Tuyl et al., 2005). These
data, in conjunction with the epithelial localization of HIF1a protein
in the developing mouse and human lung (Fig. 1E and (Groenman
et al., 2007)), led us to hypothesize that the hypoxia-induced phe-
notype seen ex vivo was driven by increased expression of HIF1a
in the epithelium. However, in our transgenic model, epithelial
HIF1a TPM expression resulted in the opposite phenotype, charac-
terized by decreased airway branching and vascular leak. Several
possibilities exist for which to explain these phenotypic differences.
First, the level of epithelial HIF1a expression in the HIF1a TPM mice
may have been higher than that observed in hypoxia-cultured lungs,
thereby activating alternative molecular pathways or amplifying
overlapping pathways that result in distinct phenotypes. Second, al-
though the expression pattern of HIF1a in hypoxia-cultured lungs
was not reported at the cellular level (van Tuyl et al., 2005), one
would predict that all cells within the lung would stabilize HIF1a
protein since HIF1a mRNA is ubiquitously expressed. Therefore, an
alternative explanation is that hypoxia-induced HIF1a expression
in the mesenchymal cells of the explant model promotes branching
and hypervascularity. Third, it is also possible that HIF1a-
independent hypoxia effects, including stabilization of EPAS1, acti-
vation of the unfolded protein response and downstream target
genes (Koritzinsky et al., 2006) and/or increased translation of se-
lective mRNAs including VEGFA (Young et al., 2008), contributed
to the hypoxia-mediated increase in airway branching and vascular
morphogenesis ex vivo that was not observed in our model. Lastly,
although the HIF1a TPM protein is more stable and transcriptionally
active that wild type HIF1a (Fig. 3), its structure and/or function
may differ from that of endogenous HIF1a, contributing to the ob-
served phenotype.
It has been demonstrated that HIF1a protein and several HIF1a
target genes, including Vegfa, Vegfc and Bhlhb2, are increased in pa-
tients with two distinct forms of chronic lung disease, idiopathic pul-
monary ﬁbrosis (IPF) and cryptogenic organizing pneumonia, and in a
bleomycin-induced animal model of pulmonary ﬁbrosis (Tzouvelekis
et al., 2007). In the IPF lung, HIF1a protein is primarily localized to the
alveolar epithelial cells immediately overlying or adjacent to the ﬁ-
broblastic foci, the histological hallmarks of this disease. Increased
lymphangiogenesis has also reported in patients with IPF and in the
bleomycin-induced pulmonary ﬁbrosis model (El-Chemaly et al.,
2009; Teles-Grilo et al., 2005). While total VEGFA, VEGFC and
VEGFD levels were not increased in bronchoalveolar lavage ﬂuid
from IPF patients, it may be the local bioavailability of these pro-
lymphatic factors, or the VEGFR3 receptor itself, that is important in
promoting the lymphangiogenic process. Although these observa-
tions are correlative in nature, it is tempting to speculate that stabili-
zation of HIF1a protein in the early stages of the ﬁbrotic process
drives lymphangiogenesis in the IPF lung via the VEGF and Notch sig-
naling pathways, potentially contributing to the pathophysiology of
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